Ligand validation:6I71

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 6I71 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6I71_SAH_A_401	100%	44%	0.037	0.989	0.94	1.21	1	2	0	0	100%	1
6I71_SAH_B_401	100%	37%	0.039	0.986	1.04	1.44	3	5	0	0	100%	1
6I73_SAH_A_401	100%	49%	0.028	0.992	0.78	1.16	-	2	0	0	100%	1
6I72_SAH_A_401	100%	40%	0.037	0.987	0.98	1.35	2	3	0	0	100%	1
6YJW_SAH_B_401	98%	34%	0.052	0.978	1.15	1.44	3	3	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
6U8W_SAH_A_901	100%	22%	0.028	0.995	1.23	1.96	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.